USD Partners LP (USDP): Nasdaq/NYSE listing notice — NYSE warns USD Partners LP of non-compliance due to unit price below $1.00 average

USD Partners LP

NYSE notified USDP on July 26, 2023 that its common units' average closing price was below $1.00 over 30 consecutive trading days.
Partnership has 10 business days to respond with intent to cure, then a six-month cure period to regain compliance.
Common units continue trading on NYSE with '.BC' designation; no impact on business operations or debt agreements.
Can regain compliance if closing price ≥$1.00 on last trading day of any month during cure period and average over 30 days ≥$1.00.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

USD Partners LP received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

July 26, 2023, USD Partners LP (the “Partnership”) received a notice from the New York Stock Exchange (“NYSE”) that it is not in compliance with the continued listing criteria under Section 802.01C of the NYSE's Listed Company Manual, because the average closing price of the Partnership's common units was less than $1.00 over a consecutive 30 trading-day period. Under the applicable rules of the NYSE, the Partnership will respond to the NYSE within ten business days of receipt of the non-compliance notice with respect to its intent to cure the deficiency to regain compliance with the average c

View on SEC.gov

Browse all listing & compliance notices →

USD Partners LP filing history →

Source: SEC EDGAR

accession 0001610682-23-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.